Syndax Pharmaceuticals
Price & Volume
Stats
See more52W Range | $8.58-$22.73 |
Market Cap | $1.8B |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $111.3M |
Revenue Growth (YoY) | 267% |
Gross Profit (12 Mos) | -$133.2M |
Diluted EPS | -$3.60 |
News
See moreYahoo Finance • 20 days ago
Syndax Highlights Leadership in Menin Inhibition at ASH 2025 with Multiple Revuforj® (revumenib) Presentations Spanning the Acute Leukemia Treatment Continuum
Yahoo Finance • 25 days ago
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Yahoo Finance • 27 days ago
Syndax Announces Participation at the 8th Annual Evercore Healthcare Conference
Yahoo Finance • 30 days ago
Barclays Raises Syndax (SNDX) PT to $35 on Positive Management Update, Model Rerating
About
CEO | Mr. Michael A. Metzger M.B.A. |
CFO | Mr. Keith Alan Goldan CPA |
Address | 730 Third Avenue, New York, NY, United States, 10017 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 270 |
